| Registry | NCT02120066 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; na, single group, masking: none, treatment |
| Enrollment | 22 (Actual) |
| Sponsor | Kyorin University (Other) |
| Conditions | Submacular Hemorrhage, Ruptured Retinal Arterial Macro Aneurysms |
| Interventions | Vitrectomy for submacular hemorrhage, subretinal injection of tissue-plasminogen activator (Procedure, drug) |
| Dates | start 2011-01-01, primary completion 2013-06-01, completion 2014-04-01, first posted 2014-04-22, last updated 2014-04-22 |
| Locations | 1 site in Japan |
Related Papers Related Patents Related Grants Related Experts
All trials for Submacular Hemorrhage All trials for Ruptured Retinal Arterial Macro Aneurysms All trials of Vitrectomy for submacular hemorrhage All trials of subretinal injection of tissue-plasminogen activator
Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Vitrectomy | Other | Procedure: Vitrectomy for submacular hemorrhage; Drug: subretinal injection of tissue-plasminogen activator |
Sex: All, ages: 40 Years to 95 Years
Inclusion Criteria: * The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms Exclusion Criteria: * The eyes with preretinal or intraretinal hemorrhage at the fovea * The patients with follow-up less than 3 months
| Facility | City | Country | Status |
|---|---|---|---|
| Kyorin Eye Center | Mitaka, Tokyo | Japan |